What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Jan Novak mostly deals with Immunology, Nephropathy, Glomerulonephritis, Immunoglobulin A and Antibody.
His Nephropathy research is multidisciplinary, relying on both Biomarker, Genetics, Internal medicine, Case-control study and Genome-wide association study.
He has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Immune complex.
His Glomerulonephritis research includes elements of Kidney disease, Nephritis and Immunopathology.
His Immunoglobulin A study is associated with Immunoglobulin G.
His Antibody research incorporates elements of Pathogenesis, Glycosylation, Immune system, Molecular biology and Flagellin.
His most cited work include:
- Genome-wide association study identifies susceptibility loci for IgA nephropathy (376 citations)
- The Pathophysiology of IgA Nephropathy (345 citations)
- Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies (345 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Nephropathy, Immunology, Internal medicine, Immune system and Glomerulonephritis.
In his research, Bioinformatics is intimately related to Disease, which falls under the overarching field of Nephropathy.
Jan Novak interconnects Biomarker and Biomarker discovery in the investigation of issues within Bioinformatics.
His Kidney research extends to the thematically linked field of Immunology.
His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Cardiology.
As a part of the same scientific family, Jan Novak mostly works in the field of Antibody, focusing on Glycosylation and, on occasion, Glycan, Lectin and Receptor.
He most often published in these fields:
- Nephropathy (26.65%)
- Immunology (26.14%)
- Internal medicine (22.59%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (22.59%)
- Nephropathy (26.65%)
- Cardiology (6.85%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Nephropathy, Cardiology, Immune system and Immunology.
The Internal medicine study combines topics in areas such as Gastroenterology and Diabetes mellitus.
He has included themes like Glomerulonephritis, Kidney, Membranous nephropathy, Disease and IgA vasculitis in his Nephropathy study.
The concepts of his Immune system study are interwoven with issues in Autoantibody, Cancer research, Glycosylation and Computational biology.
His Autoantibody study integrates concerns from other disciplines, such as Proteinuria, Pathogenesis and Renal biopsy.
As part of his studies on Immunology, Jan Novak often connects relevant subjects like Galactose.
Between 2017 and 2021, his most popular works were:
- Glycosylation in health and disease. (219 citations)
- Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation (56 citations)
- Secondary IgA nephropathy (33 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Jan Novak spends much of his time researching Nephropathy, Immune system, Internal medicine, Immunology and Glycosylation.
His Nephropathy research integrates issues from Glomerulonephritis, Kidney, Membranous nephropathy, Autoantibody and Disease.
His work deals with themes such as Proteinuria, Pathogenesis and Renal biopsy, which intersect with Autoantibody.
Jan Novak is interested in Immune complex, which is a branch of Immune system.
In the subject of general Internal medicine, his work in Cohort, Prospective cohort study, Renal function and Endomyocardial biopsy is often linked to In patient, thereby combining diverse domains of study.
His studies deal with areas such as Receptor, Antibody and Glycan as well as Glycosylation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
